Product
CDKI AT7519
1 clinical trial
3 indications
Indication
lymphomaIndication
solid tumorIndication
Protocol SpecificClinical trial
A Phase I Study of AT7519M Given Twice Weekly in Patients With Advanced Incurable MalignancyStatus: Completed, Estimated PCD: 2012-03-13